Contact us to learn more about

our Premium Content: News alerts, weekly reports and conference planners

BIOMARKER:

EGFR exon 19 deletion + EGFR T790M + EGFR C797S

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Non Small Cell Lung Cancer	osimertinib + anlotinib Sensitive: C3 – Early Trials osimertinib + anlotinib Sensitive : C3	osimertinib + anlotinib Sensitive: C3 – Early Trials osimertinib + anlotinib Sensitive : C3
EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Lung Adenocarcinoma	EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Lung Adenocarcinoma	brigatinib Sensitive: C4 – Case Studies brigatinib Sensitive : C4	brigatinib Sensitive: C4 – Case Studies brigatinib Sensitive : C4
EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Non Small Cell Lung Cancer	EGFR exon 19 deletion + EGFR T790M + EGFR C797S	Non Small Cell Lung Cancer	BI-732 Sensitive: D – Preclinical BI-732 Sensitive : D	BI-732 Sensitive: D – Preclinical BI-732 Sensitive : D